"Clinically predictive preclinical efficacy testing services at your disposal"


Jussi Halleen - CEO, Pharmatest Services

Pharmatest Services Ltd attends ASBMR Annual Meeting in Seattle

Pharmatest Services Ltd attends Annual Meeting of The American Society for Bone and Mineral Research (ASBMR) that will be held in Seattle, WA, USA on October 9 – 12, 2015. Pharmatest has four scientific presentations in the meeting and welcomes everyone to visit our booth #320.

Pharmatest Services Ltd (Pharmatest) is a contract research organization that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. ASBMR Annual Meeting is the leading scientific event in the field of bone research globally.

This year Pharmatest attends ASBMR with the following four scientific presentations:

-       Poster SA0350 on Saturday October 10: The Bone-Protective Effects of a Novel Selective Estrogen Receptor Modulator (SERM) pERD in Ovariectomized Rats (collaboration with Bayer AG)

-       Poster SU0176 on Sunday, October 11: Epiphyseal Bone, Subchondral Bone Plate and Epiphyseal Trabecular Bone in Surgically and Chemically Induced Rat Models of Osteoarthritis (funded by Eurostars program of EU)

-       Poster MO0212 on Monday, October 12: Denosumab and Odanacatib as Reference Compounds in Human Osteoclast Cultures

-       Poster MO0348 on Monday, October 12: The Effects of a Novel Selective Estrogen Receptor Modulator (SERM) pERD on Bone Health in Intact Female Rats (collaboration with Bayer AG)

Pharmatest welcomes everyone to visit our posters and booth #320 in the event. If you would like to schedule a meeting with our representatives during the ASBMR meeting, click here.